Clinical applications of next‐generation sequencing‐based gene panel in patients with muscular dystrophy: Korean experience

Muscular dystrophy (MD) is a genetically and clinically heterogeneous group of disorders. Here, we performed targeted sequencing of 18 limb‐girdle MD (LGMD)‐related genes in 35 patients who were highly suspected of having MD. We identified one or more pathogenic variants in 23 of 35 patients (65.7%), and a genetic diagnosis was performed in 20 patients (57.1%). LGMD2B was the most common LGMD type, followed by LGMD1B, LGMD2A, and LGMD2G. Among the three major LGMD types in this group, LGMD1B was correlated with the lowest creatine kinase (CK) levels and the earliest onset, whereas LGMD2B was correlated with the highest CK levels and the latest onset. Thus, next‐generation sequencing‐based gene panels can be a helpful tool for the diagnosis of MDs, particularly in young children and those displaying atypical symptoms.

[1]  V. Nigro,et al.  Genetic basis of limb-girdle muscular dystrophies: the 2014 update , 2014, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[2]  Y. Itoyama,et al.  Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  Lan-Fang Zhou,et al.  The diagnostic utility of a commercial limb-girdle muscular dystrophy gene test panel. , 2012, Journal of clinical neuromuscular disease.

[4]  T. Nam,et al.  Two common mutations (p.Gln832X and c.663+1G>C) account for about a third of the DYSF mutations in Korean patients with dysferlinopathy , 2012, Neuromuscular Disorders.

[5]  Y. Itoyama,et al.  Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2 B , 2012 .

[6]  C. Béroud,et al.  Analysis of the DYSF mutational spectrum in a large cohort of patients , 2009, Human mutation.

[7]  S. Salani,et al.  Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients , 2008, Human mutation.

[8]  F. Spaans,et al.  Limb-girdle muscular dystrophy in the Netherlands: Gene defect identified in half the families , 2007, Neurology.

[9]  I. Nonaka,et al.  Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients , 2003, Journal of the Neurological Sciences.

[10]  K. Mathews,et al.  Limb-girdle muscular dystrophy , 2003, Current neurology and neuroscience reports.

[11]  I. Nonaka,et al.  Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy , 2001, Neuromuscular Disorders.

[12]  M. Passos-Bueno,et al.  Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes , 2000, Current opinion in neurology.

[13]  I. Nonaka,et al.  Mutations of calpain 3 gene in patients with sporadic limb-girdle muscular dystrophy in Japan , 1999, Journal of the Neurological Sciences.